Milestone Scientific, Inc.
MLSS
Positions held
Your positionsMLSS isn't in your positions.
Add it to see shares, cost, and P&L here.
Fundamentals
| Market cap | $32.62M | Enterprise value | $30.50M | Trailing P/E | — | Forward P/E | -10.29 |
| PEG | — | Price / book | 9.23 | Beta | 1.13 | Dividend yield | 0.00% |
| Revenue growth | 22.3% | Earnings growth | — | Gross margin | 70.2% | Operating margin | -37.4% |
| Profit margin | -44.0% | ROE | -121.7% | ROA | -31.3% | Debt / equity | 0.18 |
| Current ratio | 1.85 | Free cash flow | $981,640 | Analyst recommendation | none | Mean target | $1.25 |
| 52w high | $0.58 | 52w low | $0.22 |
Quarterly
| 2026-Q2 | 2026-Q1 | 2025-Q4 | 2025-Q3 | 2025-Q2 | 2025-Q1 | |
|---|---|---|---|---|---|---|
| Revenue | $2.8M | $2.2M | $2.1M | $2.4M | $2.3M | — |
| Op margin | -37.4% | -38.3% | -52.5% | -48.1% | -63.9% | — |
| Net income | -$1.1M | -$0.8M | -$1.1M | -$1.2M | -$1.5M | — |
| Gross margin | 67.2% | 72.3% | 73.0% | 69.5% | 69.6% | — |
| Gross profit | $1.9M | $1.6M | $1.5M | $1.6M | $1.6M | — |
| Operating income | -$1.1M | -$0.8M | -$1.1M | -$1.1M | -$1.5M | — |
- Revenue +31% vs prior quarter ($2.8M vs $2.2M).
- Gross margin 67.2% (was 72.3% prior quarter).
Yearly (6y)
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Revenue | $9.0M | $8.6M | $9.8M | $8.8M | — |
| Op margin | -63.5% | -78.3% | -72.3% | -100.2% | — |
| Net income | -$5.7M | -$4.7M | -$6.9M | -$8.7M | — |
| Gross margin | 71.4% | 74.6% | 69.1% | 55.7% | — |
| Gross profit | $6.4M | $6.4M | $6.8M | $4.9M | — |
| Operating income | -$5.7M | -$6.8M | -$7.1M | -$8.8M | — |
No flags
• No distress or material-risk keywords in recent headlines (keyword scan only — not a guarantee).
News
2026-09-29 · Milestone Scientific Highlights Building a Scalable Growth Platform for CompuFlo® Medical Business
2026-08-26 · Milestone Scientific Achieves Debt-Free Balance Sheet Through Debt-to-Equity Conversion by Three Directors
2026-08-14 · Milestone Scientific Inc (MLSS) (Q2 2026) Earnings Call Highlights: Revenue Surges 22% on ...
2026-08-14 · Milestone Scientific Inc. Q2 2026 Earnings Call Summary
2026-08-14 · Milestone Scientific Reports Financial Results for Second Quarter 2026
2026-08-13 · Earnings To Watch: Milestone Scientific Inc (MLSS) Q2 2026 -- GF Value Sees 13% Upside
2026-08-06 · Milestone Scientific Schedules Second Quarter 2026 Financial Results Conference Call
Price (daily)
Full chart · RSI · MACD · patterns